During a dedicated symposium, Dr. Mads Nybo presented results from the GEM Premier 7000 study conducted at Odense University Hospital, Denmark.
With more than 80 laboratory and clinical experts from across the Nordic countries in attendance, the symposium provided a strong platform to raise awareness of the clinical impact of hemolysis and demonstrate how the GEM Premier 7000 can help address this important preanalytical challenge in clinical practice.
A strong step forward for the EEMEA team in Denmark, building connections, fostering scientific dialogue, and showcasing the GEM Premier 7000 value across the Nordic region.




